Tuesday, July 09, 2024 11:56:01 AM
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer
Prior Studies where for early stage breast cancer now there is incredible data for dealing with later stage and higher risk breast cancer patients. This is big news it moves when it moves I will keep adding at these levels!
Prior Studies where for early stage breast cancer now there is incredible data for dealing with later stage and higher risk breast cancer patients. This is big news it moves when it moves I will keep adding at these levels!
Bullish
Recent ICCM News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:25 AM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 04/01/2026 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 12:49:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 10:11:32 AM
- IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 03/26/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 12:45:01 PM
- IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates • PR Newswire (US) • 03/25/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 12:45:08 PM
- IceCure Appoints Meir Peleg as Chief Financial Officer • PR Newswire (US) • 03/24/2026 12:30:00 PM
- Form F-3/A - Registration statement by foreign private issuers: [Amend] • Edgar (US Regulatory) • 03/20/2026 08:02:02 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/20/2026 08:01:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/17/2026 08:05:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/17/2026 01:03:37 PM
